Nicox submits New Drug Application for AC-170 to U.S. FDA
SOPHIA ANTIPOLIS, France, April 19, 2016 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic company, today announced the submission, through its American subsidiary Nicox Ophthalmics, Inc., of a New Drug …